Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1980-02-12
1985-06-04
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544238, 544295, 544296, 544311, 544320, 544231, 548193, A61K 31505, C07D41914, C07D41714
Patent
active
045214182
ABSTRACT:
The compounds are guanidinothiazolyl derivatives which are histamine H.sub.2 -antagonists. A specific compound of the present invention is 2-[2-(2-guanidino-4-thiazolylmethylthio)ethylamino]-5-(6-methyl-3-pyridylm ethyl)-4-pyrimidone.
REFERENCES:
patent: 3932644 (1976-01-01), Durant et al.
patent: 3980781 (1976-09-01), Snell et al.
patent: 4145546 (1979-03-01), Brown et al.
patent: 4154834 (1979-05-01), Brown et al.
patent: 4159329 (1979-06-01), Brown et al.
patent: 4165377 (1979-08-01), Jones et al.
patent: 4165378 (1979-08-01), Gilman et al.
patent: 4216318 (1980-08-01), Brown et al.
Brown Thomas H.
Durant Graham J.
Foggio Richard D.
Hollrah Glennon H.
Keps Joan S.
Lourie Alan D.
Smith Kline & French Laboratories Limited
LandOfFree
Guanidinothiazolyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidinothiazolyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidinothiazolyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-828314